Apoferritin: a potential nanocarrier for cancer imaging and drug delivery

Expert Rev Anticancer Ther. 2021 Aug;21(8):901-913. doi: 10.1080/14737140.2021.1910027. Epub 2021 Apr 12.

Abstract

Introduction: As a protein-based biomaterial for potential cancer targeting delivery, apoferritin has recently attracted interest.Areas covered: In this review, we discuss the development of this cage-like protein as an endogenous nanocarrier that can hold molecules in its cavity. We present the specific characterizations and formulations of apoferritin nanocarriers, and outline the recent progress of the protein as an appropriate tumor-delivery vehicle in different therapeutic strategies to treat solid tumors. Finally, we propose how the application for cancer drug repurposing delivery within apoferritin could expand cancer treatment in the future.Expert opinion: Being a ubiquitous iron storage protein that exists in many living organisms, apoferritin is promising as a cancer tumor-targeting nanocarrier. By exploiting its versatility, apoferritin could be used for cancer repurposed drug delivery and could reduce the high cost of new drug discovery development and shorten the formulation process.

Keywords: Apoferritin; cancer drug delivery; cancer imaging; cancer repurposed drug; tumor targeting.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Apoferritins
  • Drug Carriers
  • Drug Delivery Systems / methods
  • Humans
  • Nanoparticles*
  • Neoplasms* / drug therapy
  • Pharmaceutical Preparations*

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Pharmaceutical Preparations
  • Apoferritins